Smart Patients Get Smart Care™

The World’s Leading Authority for Chronic Lymphocytic Leukemia Patients


The team at Ohio State University Comprehensive Cancer Center used Surveillance, Epidemiology, and End Results (SEER) data to determine how race and socioeconomic status (SES) affect survival for those with CLL. SEER is a free resource of the NIH, specifically the National Cancer Institute (NCI), and is “an authoritative